Validation of a Composite Real-World Mortality Variable Among Patients With Hematologic Malignancies Treated in the United States
Our study found that a composite mortality variable leveraging multiple data sources yields high validity when compared against the gold-standard NDI. Given evidence highlighting the challenges of mortality data documentation in the real-world setting, the use of a composite mortality variable can provide significant benefits in quality of documentation and research results.
Authors
- Ching-Kun Wang
- Ming He
- Sharlene Dong
- Eric Hansen (ORCID: https://orcid.org/0000-0003-2829-1316)
- Ankit Kansagra (ORCID: https://orcid.org/0000-0001-6901-0782)
- Anna Barcellos (ORCID: https://orcid.org/0000-0002-2168-7919)
- Claire Bai
- Andrew J. Belli
- Gurbakhash Kaur (ORCID: https://orcid.org/0000-0002-2510-6536)
- Christina M. Zettler (ORCID: https://orcid.org/0000-0002-7516-593X)
- Laura L. Fernandes (ORCID: https://orcid.org/0000-0002-5986-3885)
- Jacob P. Ambrose (ORCID: https://orcid.org/0000-0001-7157-0834)
Institutions
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JCO Clinical Cancer Informatics
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/cci-24-00233
- Citations
- 3
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 3.14